MedTrace Logo

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)

NCT06417411 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2024-05-16

No results posted yet for this study

Summary

This study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being followed in two county hospitals in Angola, in the first trimester versus the second trimester of the gestational period.

Conditions

Interventions

DRUG

Aspirin 100mg

Daily use of low dose aspirin.

Sponsors & Collaborators

  • FUNDACIÓN BANCARIA CAIXA D'ESTALVIS I PENSIONS DE BARCELONA

    collaborator UNKNOWN

  • FUNDAÇAO CALOUSTE GULBENKIAN

    collaborator UNKNOWN

  • CLINCOORD SERVICES, INC.

    collaborator UNKNOWN

  • CLINCOORD PRESTAÇÃO DE SEVIÇOS, LDA ANGOLA

    collaborator UNKNOWN

  • Escola Superior de Tecnologia da Saúde de Lisboa

    collaborator OTHER

  • ClinCoord Research Center at Luanda Medical Center

    collaborator UNKNOWN

  • Instituto Nacional de Investigacao em Saude, Angola

    lead OTHER_GOV

Principal Investigators

  • JOANA MORAIS, PhD · INSTITUTO NACIONAL DE INVESTIGAÇÃO EM SAÚDE

  • TATIANA GOMES, BA/BS/Pre-MD · ClinCoord

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-16
Primary Completion
2025-03-16
Completion
2026-03-16

Countries

  • Angola

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06417411 on ClinicalTrials.gov